SATS vs. TEVA
SATS (EchoStar Corporation) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. SATS operates in Communication Equipment (Technology), while TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, SATS returned 82.88%/yr vs -3.83%/yr for TEVA. At a 0.26 correlation, their price movements are largely independent.
Performance
SATS vs. TEVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SATS achieves a 4.95% return, which is significantly lower than TEVA's 10.96% return. Over the past 10 years, SATS has outperformed TEVA with an annualized return of 82.88%, while TEVA has yielded a comparatively lower -3.83% annualized return.
SATS
- 1D
- -10.97%
- 1M
- -14.37%
- YTD
- 4.95%
- 6M
- 6.25%
- 1Y
- 531.15%
- 3Y*
- 87.23%
- 5Y*
- 33.39%
- 10Y*
- 82.88%
TEVA
- 1D
- 0.20%
- 1M
- -4.47%
- YTD
- 10.96%
- 6M
- 16.25%
- 1Y
- 95.54%
- 3Y*
- 66.30%
- 5Y*
- 25.53%
- 10Y*
- -3.83%
SATS vs. TEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SATS EchoStar Corporation | 4.95% | 374.67% | 38.20% | -0.66% | -36.70% | 24.35% | -51.07% | 16,499.32% | -38.70% | 16.56% |
TEVA Teva Pharmaceutical Industries Limited | 10.96% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
Correlation
The correlation between SATS and TEVA is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2008 | 0.26 |
Fundamentals
SATS:
$32.97B
TEVA:
$40.83B
SATS:
-$80.77
TEVA:
$1.34
SATS:
2.22
TEVA:
2.33
SATS:
5.85
TEVA:
4.96
SATS:
$14.80B
TEVA:
$17.35B
SATS:
$5.79B
TEVA:
$9.03B
SATS:
-$16.89B
TEVA:
$3.05B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SATS vs. TEVA — Risk / Return Rank
SATS
TEVA
SATS vs. TEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EchoStar Corporation (SATS) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SATS | TEVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.59 | ||
| Sortino ratioReturn per unit of downside risk | +2.43 | ||
| Omega ratioGain probability vs. loss probability | 1.80 | 1.47 | +0.33 |
| Calmar ratioReturn relative to maximum drawdown | 26.91 | 4.41 | +22.50 |
| Martin ratioReturn relative to average drawdown | 48.80 | 12.66 | +36.14 |
Loading charts...
Drawdowns
SATS vs. TEVA - Drawdown Comparison
The maximum SATS drawdown since its inception was -78.33%, smaller than the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for SATS and TEVA.
Loading charts...
Drawdown Indicators
| SATS | TEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.33% | -90.89% | +12.56% |
Max Drawdown (1Y)Largest decline over 1 year | -19.91% | -21.79% | +1.88% |
Max Drawdown (3Y)Largest decline over 3 years | -59.22% | -43.70% | -15.52% |
Max Drawdown (5Y)Largest decline over 5 years | -68.02% | -43.70% | -24.32% |
Max Drawdown (10Y)Largest decline over 10 years | -78.33% | -88.41% | +10.08% |
Current DrawdownCurrent decline from peak | -19.55% | -48.81% | +29.26% |
Average DrawdownAverage peak-to-trough decline | -31.21% | -32.00% | +0.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.97% | 7.72% | +3.25% |
Volatility
SATS vs. TEVA - Volatility Comparison
EchoStar Corporation (SATS) has a higher volatility of 22.65% compared to Teva Pharmaceutical Industries Limited (TEVA) at 10.61%. This indicates that SATS's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SATS | TEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.65% | 10.61% | +12.04% |
Volatility (6M)Calculated over the trailing 6-month period | 41.93% | 23.72% | +18.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 106.03% | 39.04% | +66.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.48% | 42.82% | +26.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 4,550.46% | 47.35% | +4,503.11% |
Dividends
SATS vs. TEVA - Dividend Comparison
Neither SATS nor TEVA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SATS EchoStar Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 85.50% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
SATS vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between EchoStar Corporation and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SATS vs. TEVA - Profitability Comparison
SATS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a gross profit of 1.67B and revenue of 3.67B. Therefore, the gross margin over that period was 45.5%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
SATS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported an operating income of 392.85M and revenue of 3.67B, resulting in an operating margin of 10.7%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
SATS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a net income of -189.14M and revenue of 3.67B, resulting in a net margin of -5.2%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
Frequently Asked Questions
SATS and TEVA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SATS has higher volatility (22.65%) compared to TEVA (10.61%). In terms of maximum drawdown, SATS dropped -78.33% vs TEVA's -90.89%.
SATS currently has the higher Sharpe Ratio (5.06 vs 2.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SATS and TEVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer